RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma

RTP Live from Chicago: Investigator Perspecti...

Up next

Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from the 2023 ASH Annual Meeting

Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome. 

CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.CME information and select publications here.